维普期刊资源整合服务平台（V6.5）

57篇 您的检索式：作者名="OKIMOTO R"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Drug combinations with amoxycillin reduce selection of clarithromycin resistance during Helicobacter pylori eradication therapy显示文摘	K Murakami T Fujioka T Okimoto R Sato M Kodama M Nasu	2002	International Journal of Antimicrobial Agents2002，，1：	2
2	Development of cor- pus atrophic gastritis may be associated with Helicobacter pylo- ri-related idiopathic thrombocytopenic purpura显示文摘	Sato R Murakami K Okimoto T	2011	J Gastroen- terol2011，46，8：	1
3	The mitochondrial genomes of two nematodes, Caenor- habditis elegans and Ascaris suum显示文摘	Okimoto R Macfarlane J L Clary D O	1992	Genetics1992，130，：	1
4	Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small cell lung cancer to gefitinib 显示文摘	Lynch TJ Bell DW Sordella R Gurubhagavatula S Okimoto RA Brannigan BW	2004	N Engl J Med2004，350，21：	1
5	Applicability of (SBE) 7m-β-CD in controlled-porosity osmotic pump tablets (OPTs) 显示文摘	Okimoto K Tokunaga Y Ibuki R	2004	IntJPharm2004，286，12：	1
6	The anaerobic proteins of maize显示文摘	SACHS M M FREELING M OKIMOTO R	1980	Cell1980，20，：	1
7	Applicability of (SBE) 7m- beta- CD in controlled- porosity osmotic pump tablets (OPTs) 显示文摘	Okimoto K Tokunaga Y Ibuki R	2004	Int J Pharm2004，286，12：	1
8	Applicability of (SBE) 7M-beta-CD in controlled-porosity osmotic pump tablets (OPTs)显示文摘	Okimoto K Tokunaga Y lbuki R	2004	IntJPharm2004，286，12：	1
9	The anaerobic proteins of maize显示文摘	Freeling M Okimoto R	1980	Cell1980，20，：	1
10	Mapping quantitative trait loci controlling milk production by exploiting progeny testing显示文摘	Georges M Nielsen D Mackinnon M Mishra A Okimoto R Pasquino A T Sargeant L S Sorensen A Steele M R and Zhao X	1995	Genetics1995，139，：	1
11	Nucleotide correlations that suggest tertiary interactions in the TV- replacement loop-containing mitochondrial tRNAs of the nematodes, Caenorhabditis elegans and Ascaris sum显示文摘	Wolstenholme D R Okimoto R Macfarlane J L	1994	Nucleic Acids Res1994，22，20：	1
12	Applicability of (SBE)7m-β-CD in controlled-porosity osmotic pump tablets (OPTs)显示文摘	Okimoto K Tokunaga Y J Ibuki R	2004	Int J Pharmaceutics2004，286，：	1
13	Factors affecting membrane-controlled drug release for an osmotic pump tablet (OPT) utilizing(SBE)7m-β-CD as both a solubilier and osmotic agent 显示文摘	Okimoto K Ohike A Ibuki R	1999	J Controlled Release1999，60，：	1
14	The interaction of charged and uncharged drugs with neutral ( HP - β - CD) and anionically charged (SBE7 - β - CD) β - cyclodextrin 显示文摘	Okimoto K Rajewsi R A Uekama K	1996	Pharm Res1996，13，：	1
15	Factors affecting membrane - controlled drug release for an osmotic pump tablet (OPT) utilizing (SBE)7m - β - CD as both a solubilizer and osmotic agent 显示文摘	Okimoto K Ohike A Ibuki R	1999	J Control Release1999，60，：	1
16	Release of testosterone from an osmotic pump tablet utilizing (SBE)7m - β - cyclodextrin as both a solubilizing and an osmotic pump agent 显示文摘	Okimoto K Rajewski R A Stella V J	1999	J Control Release1999，58，1：	1
17	Design and evaluation of an osmotic pump tablet(OPT)forChlorpromazine using (SBE)7m-β-CD显示文摘	Okimoto K Ohike A Ibuke R etc al	1999	PharmRes1999，16，4：	1
18	Factors affecting membrane controlled drug release for an osmotictable(OPT),utilizing (SBE)7m-β-CD as both a solubilizer and osmotic agent显示文摘	Okimoto K Ohike A Ibuke R etc al	1999	J ControlledRelease1999，60，23：	1
19	Variation of charge-or- bital correlation with Cr doping in manganites显示文摘	Kimura T Kumai R Okimoto Y	2000	Phys Rev B2000，62，15：	1
20	Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small cell lung cancer gefitinib显示文摘	Lynch TJ Bell DW Sordella R Gurubhagavatula S Okimoto RA Brannigan BW Harris PL Haserlat SM Supko JG Haluska FG Louis DN Christiani DC Settleman J Haber DA		0，，：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示